Professor of Medicine, Cleveland Cl College of Medicine/Case West Res
Cardiology
Dr. Steven E. Nissen, MD
|
|
Give Review
Steven E. Nissen is an expert in the field of Cardiology. He went to medical school at University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63 in research and 72 in primary care medicine He over the years received 3 awards: "America's Top Doctors", "Northern Ohio Live" and "Whos Who in Medicine and Healthcare". Steven E. Nissen is a published doctor. He published 98 publications, including: 'Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.' He is registered with Medicare.
Publications
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
- Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
- Effects of aliskiren in diabetic and non-diabetic patients with Coronary artery disease: Insights from AQUARIUS.
- Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
- Adults with long-duration type 2 diabetes have blunted glycemic and β-Cell function improvements after bariatric surgery.
- Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
- Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis.
- Prevention Guidelines: Bad Process, Bad Outcome.
- Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome: Insights From Study of Coronary Atheroma by Intravascular Ul...
- Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy: Insights From SATURN.
- Myeloperoxidase levels predict accelerated progression of Coronary atherosclerosis in diabetic patients: Insights from intravascular ultrasound.
- Long-term effects of maximally intensive statin therapy on changes in Coronary atheroma composition: insights from SATURN.
- Varespladib and cardiovascular events in patients with an Acute coronary syndrome: the VISTA-16 randomized clinical trial.
- C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive...
- Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial.
- Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes.
- Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
- Factors underlying regression of Coronary atheroma with potent statin therapy.
- Exploring Coronary atherosclerosis with intravascular imaging.
- Multiple risk factor intervention and progression of Coronary atherosclerosis in patients with type 2 diabetes mellitus.
- Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive m...
- The Complementary Roles of Imaging and 'Omics' for Future Anti-atherosclerotic Drug Development.
- Left main Coronary atherosclerosis progression, constrictive remodeling, and clinical events.
- Cox-2 inhibitors and cardiovascular Disease: considerable heat, but not much light.
- Spotty calcification as a marker of accelerated progression of Coronary atherosclerosis: insights from serial intravascular ultrasound.
- Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
- Coronary computed tomography angiography the challenge of Coronary calcium.
- Pharmacogenomics and clopidogrel: irrational exuberance?
- Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
- Effect of two intensive statin regimens on progression of Coronary disease.
- Downstream Coronary effects of drug-eluting stents.
- EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) A cardio...
- Risk Prediction with Serial Myeloperoxidase Monitoring in Patients with Acute Chest Pain.
- Left main trunk coronary artery Dissection as a consequence of inaccurate coronary computed tomographic angiography.
- Can we trust cardiovascular practice guidelines?: comment on "Conflicts of interest in cardiovascular clinical practice guidelines".
- Peripheral arterial disease and progression of Coronary atherosclerosis.
- Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable Coronary artery disease a randomized controlled trial.
- Medical Device Recalls and the FDA Approval Process.
- Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of Coronary atherosclerosi...
- An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung a...
- Lessons from Coronary intravascular ultrasound on the importance of raising high-density lipoprotein cholesterol.
- Rosiglitazone revisited: an updated meta-analysis of risk for Myocardial infarction and cardiovascular mortality.
- Plaque progression in Coronary arteries with minimal luminal obstruction in intravascular ultrasound atherosclerosis trials.
- Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
- Comparison of rates of progression of Coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome.
- Intravascular ultrasound-derived measures of Coronary atherosclerotic plaque burden and clinical outcome.
- The metabolic syndrome, its component risk factors, and progression of Coronary atherosclerosis.
- Cardiovascular outcomes in randomized trials: should time to first event for "hard" end points remain the standard approach?
- Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
- Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.
- Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).
- Pioglitazone to reduce restenosis after bare-metal stent placement?
- Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
- Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end po...
- The vulnerable plaque "hypothesis": promise, but little progress.
- Low levels of low-density lipoprotein cholesterol and blood pressure and progression of Coronary atherosclerosis.
- The Jupiter trial: key findings, controversies, and implications.
- Analyses of cancer data from three ezetimibe trials.
- Limitations of computed tomography Coronary angiography.
- Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of Coronary atherosclerosis: insights from ILLUSTRATE (Investigation o...
- Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialty.
- Tim Russert and sudden cardiac death after Myocardial infarction.
- Preliminary observations from preliminary trial results: have we finally had enough?
- Effect of diabetes on progression of Coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials.
- Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative Coronary angiography, and atheroma: volume observations from the REVE...
- Late-breaking trials at the ACC scientific sessions: insights and controversy.
- ENHANCE and ACCORD: controversy over surrogate end points.
- The editor's roundtable: atherosclerosis regression.
- A much-anticipated FDA reform bill is signed into law: progress and compromise.
- Courage under fire: what is the optimal approach to initial treatment of stable Angina?
- Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after Acute myocardial in...
- Late thrombosis with drug-eluting stents: anatomy of a controversy and lessons learned.
- Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
- Perspective: effect of rosiglitazone on cardiovascular outcomes.
- Beta-blockers and progression of Coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.
- Health care disparities, the uninsured, and the role of cardiologists in the national debate.
- Effect of rosiglitazone on the risk of Myocardial infarction and death from cardiovascular causes.
- Coronary angiography for follow-up of Heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade.
- The US Food and Drug Administration: a dysfunctional agency in need of major reforms.
- Rate of progression of Coronary atherosclerotic plaque in women.
- Saving lives in Acute ST-elevation myocardial infarction: the door-to-balloon initiative.
- Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
- Comparison of Coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m(2): a meta-analysis of intravascul...
- Statins, high-density lipoprotein cholesterol, and regression of Coronary atherosclerosis.
- President's page: the ACC's international mission: learning, leading, and sharing.
- Coronary artery calcification and changes in atheroma burden in response to established medical therapies.
- President's page: "fix the formula" remains key issue in 2007.
- President's page: Keeping a commitment to our patients, our profession, and a city.
- Antihypertensive therapy and regression of Coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAM...
- President's page: GAP-D2B: an alliance for quality.
- The new era of medical imaging.
- President's page: Acute coronary care: the yardstick of value.
- Coronary atherosclerosis can regress with very intensive statin therapy.
- President's page: a new home for the American College of Cardiology.
Schools
University Of Michigan Medical School
Univ Of California Davis Medical Center
University Of Kentucky Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Northern Ohio Live
- Whos Who in Medicine and Healthcare
Education
-
University of Kentucky College of Medicine -
University of Michigan Medical School
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1871685487 | |
| NPPES Provider LastName | NISSEN | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 112.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871685487 |
| Last Name Of The Provider | NISSEN |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Sara M. Mekuria, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alaeddin M. Ayyad, MD |
|
|
Dr. Ravi N. Nair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard E. Rowen Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anthony G. Vlastaris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Grimm, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Conrad C. Simpfendorfer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ebony R. Alston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chantal A. Elamm, MD |
|
|
Dr. Abraham M. Lincoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabe K. De, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zeina S. Ibrahim, MD |